Related Experiment Video
Updated: May 24, 2026
04:32
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Ventilator-associated pneumonia: a review
Madiha Ashraf1, Luis Ostrosky-Zeichner
1Division of Infectious Diseases, University of Texas Medical School at Houston, Houston, TX 77030, USA. madiha.ashraf@uth.tmc.edu
Hospital Practice (1995)
|March 13, 2012
Summary
Ventilator-associated pneumonia (VAP) is a common ICU infection. Early diagnosis, appropriate antibiotic use with de-escalation, and proven preventive strategies are crucial for reducing VAP
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU) infection, causing significant morbidity, mortality, and increased antibiotic use.
- VAP contributes to 25% of ICU infections and 50% of antibiotic prescriptions in mechanically ventilated patients, imposing a substantial financial burden.
- Attributable mortality for VAP ranges from 8% to 15%, highlighting the critical need for effective management and prevention strategies.
Purpose of the Study:
- To review recent advancements in VAP epidemiology, risk factors, diagnostics, and management.
- To emphasize evolving diagnostic techniques and preventive measures for VAP.
- To provide actionable insights for healthcare professionals managing VAP in ICUs.
Main Methods:
- Review of current literature on VAP epidemiology and trends.
- Analysis of modifiable risk factors associated with VAP development.
- Evaluation of contemporary diagnostic approaches and treatment guidelines.
- Assessment of evidence-based preventive strategies for VAP.
Main Results:
- No definitive gold standard exists for VAP diagnosis; quantitative cultures are recommended before antibiotic initiation.
- Empirical broad-spectrum antibiotic therapy is advised upon suspicion, followed by de-escalation based on results or clinical response.
- Optimal antibiotic treatment duration is suggested at 8 days, with exceptions for specific pathogens or comorbidities.
- Proven preventive measures include noninvasive ventilation, semirecumbent positioning, subglottic secretion drainage, and chlorhexidine oral care.
Conclusions:
- Effective VAP management requires a multi-faceted approach encompassing timely diagnosis, judicious antibiotic use, and de-escalation.
- Preventive strategies are paramount in reducing the incidence and impact of VAP in critically ill patients.
- Adherence to evidence-based preventive measures can significantly decrease VAP-associated morbidity and mortality.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: